Use access key #2 to skip to page content.
$15.37 0.23 (1.52%)
7/8/2008 4:00 PM

PharmaNet Development Group, Inc. (PDGI)

CAPS Rating:
**

A drug development services company, providing a range of both early and late stage clinical drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies around the world.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating PDGI

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

53 Outperforms
10 Underperforms
 

All-Stars

10 Outperforms
5 Underperforms
 

Wall Street

2 Outperforms
1 Underperforms
 

Players bullish on PDGI are also bullish on:

Players bearish on PDGI are also bearish on:

Ticker Tags

Small Cap (1922), Research Services (46)
Suggest a tag

PharmaNet Development Group, Inc. At A Glance

Current Price: $15.37
Last Trade Time: 7/8/2008 4:00 PM
Open: $0.00
Previous Close: $15.37
Daily Range: $14.89 - $15.55
52-Week Range: $13.45 - $43.05
Volume: 280,796
Market Cap: $297.04M
P/E Ratio: 37.28
Compare Our Special Broker Offers!

Stock Trends

PDGI VS S&P 500 (SPY)

PDGI 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for PDGI

More Headlines...

Top Bull Pitch

Recs

2

PharmaNet Development Group, Inc. (PDGI)

Avatar DWilsonDVM (25.27) Submitted: 9/21/06 5:37 AM

Formerly SFBC Int'l (SFCC), This company was blasted by bad press last year. Most, but not all is false. All the guilty players have since left the company and it has lost much of it's highly profitable stage I clinical trials. Margins have decreased, but should now have stabilized. Revenues continu...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 6 :   1 2 Next »

Recs

0

 (PDGI)

Avatar greenretriever (< 20) Submitted: 5/01/08 11:53 AM : Outperform Start Price: $17.18 PDGI Score: -1.80

Beyond 52 week low stock price is down due to bad news will be going back up soon.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PDGI)

Avatar damnishoulda (21.56) Submitted: 3/17/07 4:31 PM : Outperform Start Price: $23.95 PDGI Score: -27.16

My turnaround pick, Pharmanet is well positioned in an ever-expanding niche in the drug research market. Hopefully management learns from past blunders :)...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PDGI)

Avatar BfloBull (99.35) Submitted: 12/08/06 11:44 AM : Outperform Start Price: $22.59 PDGI Score: -21.79

earnings growth, turnaround

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PDGI)

Avatar bborden51 (< 20) Submitted: 11/24/06 4:29 PM : Outperform Start Price: $22.40 PDGI Score: -22.11

On the turnaround.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PDGI)

Avatar rmacklin (< 20) Submitted: 10/03/06 7:32 PM : Outperform Start Price: $18.96 PDGI Score: -14.36

Damage control seems to be working. Can management really be trusted? If so, this is a major value. If not, ....

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 6 :   1 2 Next »

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJesupLamont 43.90 05/05/08 05/05/08 Underperform NS $15.03+2.26%-9.82%-12.08
TrackUBS 96.39 10/18/07 10/18/07 Outperform NS $35.24-56.38%-17.20%-39.18
TrackStanfordRes 44.33 11/03/06 11/03/06 Outperform NS $20.08-23.46%-7.34%-16.12

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners